Anti-Hypertensive Drugs Market– Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2017 – 2025, the global anti-hypertensive drugs market was valued at USD 32,987.4 Mn in 2017, and is expected to reach USD 39,116.7 Mn by 2025, expanding at a CAGR of 1.2% from 2017 to 2025.
Hypertension is commonly observed chronic condition, in which the blood pressure is elevated abnormally both systolic and diastolic. This is major risk factor for causing cardiovascular, renal or endocrine disorder. The normal blood pressure level is 120-140mm Hg systolic and 60-90mm Hg diastolic any elevation above it is considered as hypertension. The major reason for the rise in prevalence of hypertension is lifestyle change, unhealthy food habits and demographic ageing. Anti-hypertensive drugs are used to reduce the level of blood pressure, different drug class of drugs with different mechanism of action exist in the market. The antihypertensive market is growing with increased patient pool especially geriatric population and extensive research and development for novel pipeline drug. The global antihypertensive market show robust growth in forecast period, but it face threat of genericization and increased competition due to patent expiry.
Browse Full Report Visit :- http://www.acutemarketreports.com/report/anti-hypertensive-drugs-market
Anti-Hypertensive are categorized by drug class type as Diuretics, Angiotensin receptor blockers (ARBs), Angiotensin converting enzyme (ACE) inhibitors, Beta blockers, Alpha blockers, Calcium channel blockers, Renin inhibitors and Vasodilators.
Market Competition Assessment:
Key players in the global Anti-Hypertensive drugs market are
Novartis AG, Astra Zeneca, Pfizer Inc., Acetelion Ltd, Sanofi S.A., Merck & Co., Boehringer Ingelheim, Lupin Limited, Johnson & Johnson Ltd., Astra Zeneca Plc, Daiichi Sankyo Company Limited and Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceutical, Bayer AG etc.
Key Market Movements:
• Rising prevalence of hypertension due to various factors such as growing population, change in unhealthy lifestyle etc.
• Extensive R&D for new treatment regimen and new drug approval in pipeline
• Evolving use of combination therapy to lower the blood pressure and decrease in adverse effect
Browse All Reports of This Category :- http://www.acutemarketreports.com/category/market-research
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
Chapter 2 Executive Summary
2.1 Global Anti-Hypertensive Drugs Market Portraiture
2.2 Global Anti-Hypertensive Drugs Market Share, by Drug type, 2015 (US$ Mn)
2.3 Global Anti-Hypertensive Drugs Market, by Geography, 2015 (Value %)
Chapter 3 Global Anti-Hypertensive Drugs Market Analysis
3.2 Prescription Analysis
3.3 Market Dynamics
3.3.1 Market Drivers
18.104.22.168 Prevalence of chronic diseases
22.214.171.124 Rise in R&D and new drug approval
126.96.36.199 Adverse effects of anti-hypertensive
Our Blog: http://amanjain96.blogspot.com/ncr
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the worlds most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Name : Chris Paul
ACUTE MARKET REPORTS
Designation : Global Sales Manager
Toll Free(US/CANADA): +1-855-455-8662
Email : firstname.lastname@example.org
Website : http://www.acutemarketreports.com